These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20687396)

  • 21. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women.
    Kocak H; Oner-Iyidogan Y; Gurdol F; Oner P; Esin D
    J Clin Lab Anal; 2011; 25(3):174-8. PubMed ID: 21567464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.
    Krzyzanowska K; Mittermayer F; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Eur J Clin Invest; 2005 Mar; 35(3):208-13. PubMed ID: 15733076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopause and the Heart.
    Nkonde-Price C; Bender JR
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
    Schmitt B; Wolters M; Kressel G; Hülsmann O; Ströhle A; Kühn-Velten WN; Lichtinghagen R; Bub A; Barth SW; Stichtenoth DO; Hahn A
    Atherosclerosis; 2007 Jul; 193(1):168-76. PubMed ID: 16876171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
    Fliser D; Kielstein JT; Haller H; Bode-Böger SM
    Kidney Int Suppl; 2003 May; (84):S37-40. PubMed ID: 12694305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
    Chirinos JA; David R; Bralley JA; Zea-Díaz H; Muñoz-Atahualpa E; Corrales-Medina F; Cuba-Bustinza C; Chirinos-Pacheco J; Medina-Lezama J
    Hypertension; 2008 Dec; 52(6):1051-9. PubMed ID: 18852383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF
    Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
    Hov GG; Sagen E; Hatlen G; Bigonah A; Åsberg A; Aasarød K
    Clin Biochem; 2011 Jun; 44(8-9):642-6. PubMed ID: 21406191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
    Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
    Siroká R; Cibulka R; Rajdl D; Racek J
    Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
    Bultink IE; Teerlink T; Heijst JA; Dijkmans BA; Voskuyl AE
    Ann Rheum Dis; 2005 Sep; 64(9):1362-5. PubMed ID: 16100343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
    Pilz S; Edelmann F; Meinitzer A; Gelbrich G; Döner U; Düngen HD; Tomaschitz A; Kienreich K; Gaksch M; Duvinage A; Stahrenberg R; Kunde J; Schmidt A; März W; Wachter R; Pieske B
    J Card Fail; 2014 Dec; 20(12):923-30. PubMed ID: 25230239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal of hormone therapy and increased risk of cardiovascular disease.
    Pines A
    Climacteric; 2016 Jun; 19(3):249-51. PubMed ID: 27075839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide.
    Reimann M; Vafeiadou K; Hall WL; Dierkes J; Nilsson M; Dahlman-Wright K; Ferrari M; Huebner U; Hallund J; Bugel S; Branca F; Williams CM; Koebnick C
    Climacteric; 2006 Jun; 9(3):215-23. PubMed ID: 16766435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.